St. John's wort: natural does not necessarily mean safe
the ONA take:
According to a study published in the journal Clinical and Experimental Pharmacology and Physiology, researchers in Australia have found that adverse reactions to St. John's Wort were similar to those reported for fluoxetine.
"It's concerning to see such severe adverse reactions in our population, when people believe they are doing something proactive for their health with little risk," lead researcher Claire Hoban, of the University of Adelaide, said in a university news release.
The study showed that side effects associated with St. John's wort use included anxiety, dizziness, hypertension, nausea, and panic attacks. The authors of the study that many patients taking St. John's wort may not be aware that they are at risk for certain adverse reactions. Patients should be advised to visit a health care professional for treatment of depression rather than self-treating with natural remedies.
St. John's wort is a popular herbal product used to treat depression in some patients. It is also known to be involved in several drug-drug interactions, particularly with oral contraceptives, anticoagulants, and some anti-cancer drugs.
Adverse reactions to St. John's Wort were similar to those reported for fluoxetine.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|